PHARMOS CORP (PARS) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 34 transactions totaling $137.6K, demonstrating a bullish sentiment with $137.6K in net insider flow. The most recent transaction on Dec 30, 2010 involved a purchase of 20,000 shares valued at $2.0K.
No significant insider buying has been recorded for PARS in the recent period.
No significant insider selling has been recorded for PARS in the recent period.
Based on recent SEC filings, insider sentiment for PARS is bullish with an Insider Alignment Score of 100/100 and a net flow of $137.6K. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at PHARMOS CORP (PARS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading PARS stock, having executed 34 transactions in the past 90 days. The most active insider is Charles W. Newhall III (Executive), who has made 6 transactions totaling $2.0M.
Get notified when executives and directors at PARS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 30, 2010 | F. Johnston Robert | Executive | Purchase | 20,000 | $0.10 | $2.0K | |
| Dec 29, 2010 | F. Johnston Robert | Executive | Purchase | 54,000 | $0.10 | $5.4K | |
| Dec 23, 2010 | F. Johnston Robert | Executive | Purchase | 81,190 | $0.10 | $8.1K | |
| Dec 22, 2010 | F. Johnston Robert | Executive | Purchase | 4,970 | $0.10 | $497 | |
| Dec 21, 2010 | F. Johnston Robert | Executive | Purchase | 7,000 | $0.10 | $700 | |
| Dec 20, 2010 | F. Johnston Robert | Executive | Purchase | 6,840 | $0.10 | $684 | |
| May 8, 2009 | B. Evnin Anthony | Executive | Other | 371,129 | $0.05 | $18.6K | |
| May 8, 2009 | Fund III Lp Venrock Entrepreneurs | Executive | Other | 296,904 | $0.05 | $14.8K | |
| May 8, 2009 | Fund III Lp Venrock Entrepreneurs | Executive | Other | 7,422 | $0.05 | $371 | |
| May 8, 2009 | Fund III Lp Venrock Entrepreneurs | Executive | Other | 66,803 | $0.05 | $3.3K | |
| May 8, 2009 | B. Evnin Anthony | Executive | Other | 370,432 | $0.05 | $18.5K | |
| May 8, 2009 | W. Newhall Charles III | Executive | Award | 543,427 | $0.05 | $27.2K | |
| May 8, 2009 | Richard Kramlich C. | Executive | Other | 543,427 | $0.05 | $27.2K | |
| Apr 21, 2009 | B. Evnin Anthony | Executive | Purchase | 7,715,190 | $N/A | $0 | |
| Apr 21, 2009 | W. Newhall Charles III | Executive | Award | 3,636,364 | $0.28 | $1.0M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 9 | $2.1M | 88.6% |
Purchase(P) | 15 | $137.6K | 5.7% |
Other(J) | 10 | $136.3K | 5.7% |
Insiders at PHARMOS CORP are accumulating shares at an accelerated pace. With 9 insiders making 34 transactions totaling $137.6K in purchases versus $0 in sales, the net buying activity of $137.6K signals strong executive confidence. Charles W. Newhall III (Executive) leads the buying activity with $2.0M in transactions across all time.